K250371

Substantially Equivalent

cryoICE cryoXT cryoablation probe (cryoXT)

Applicant: AtriCure, Inc.
Product code: GXH
Advisory panel: Neurology
Date received: 2025-02-10
Decision date: 2025-04-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mason, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.